期刊文献+

子宫内膜癌组织中STAT3的表达及意义 被引量:1

The significance and expression of STAT3 in endometrial carcinoma tissues
下载PDF
导出
摘要 目的:探讨信号传导和转录活化因子3(signal transducer and activator of transcription 3,STAT3)在人子宫内膜癌组织中的表达及其与临床病理特征的相关性。方法:采用RT-PCR方法检测STAT3信使核糖核酸在30例子宫内膜腺癌组织及30例癌旁正常子宫内膜组织中的表达,采用卡方检验分析阳性表达率的差异。结果:人子宫内膜腺癌组织中STAT3 mRNA的阳性表达率明显高于癌旁正常组织的表达(67%和10%,P<0.05)。人子宫内膜腺癌组织中STAT3 mRNA的阳性表达和病理分期、分化程度、浸润深度及淋巴结转移显著相关(P<0.05),而与年龄无相关性(P>0.05)。结论:STAT3 mRNA表达上调可能是子宫内膜癌发生的重要分子事件之一。 Objective: To study the expression of signal transducer and activator of transcription 3(STAT3) in endometrial carcinoma tissues and the relationships between STAT3 and clinicopathologic characteristics. Methods: Expression of STAT 3 mRNA in 30 cases of endometrial carcinomas and 30 normal endometrial tissues was measured respectively by RT-PCR.Chi-square test was used to analyze the difference of positive expression rate in different groups. Results: Expression of STAT3 mRNA in endometrial carcinomas was significantly higher than that in normal endometrial tissues(67% vs 10%,P0.05).Expression of STAT3 mRNA was correlated with pathological staging,tumor differentiation,depth of tumor invasion,and lymph node metastasis in endometrial carcinomas(P0.05).However,expression of STAT3 mRNA was not correlated with age in endometrial carcinomas(P0.05). Conclusion: The over expression of STAT3 mRNA may be one of key molecular events for endometrial carcinogenesis.
出处 《河南医学研究》 CAS 2012年第2期133-135,共3页 Henan Medical Research
基金 国家自然科学基金(81170581) 河南省卫生厅科技攻关计划项目(2011020123)
关键词 子宫内膜癌 逆转录-聚合酶链反应 信号传导和转录活化因子3 endometrial carcinoma reverse transcription-polymerase chain reaction signal transducer and activator of transcription 3
  • 相关文献

参考文献9

  • 1Jing N,Tweardy D J.Targeting Stat3 in cancer therapy[J].AnticancerDrugs,2005,16(6):601-607.
  • 2Tang J Z,Kong X J,Banerjee A,et al.STAT3alpha is oncogenic forendometrial carcinoma cells and mediates the oncogenic effects of au-tocrine human growth hormone[J].Endocrinology,2010,151(9):4133-4145.
  • 3Gao J,Tian J,Lv Y,et al.Leptin induces functional activation of cy-clooxygenase-2 through JAK2/STAT3,MAPK/ERK,and PI3K/AKTpathways in human endometrial cancer cells[J].Cancer Sci,2009,100(3):389-395.
  • 4Pallares J,Martinez-Guitarte J L,Dolcet X,et al.Survivin expressionin endometrial carcinoma:a tissue microarray study with correlationwith PTEN and STAT-3[J].Int J Gynecol Pathol,2005,24(3):247-253.
  • 5Gong W,Wang L,Yao J C,et al.Expression of activated signal trans-ducer and activator of transcription 3 predicts expression of vascularendothelial growth factor in and angiogenic phenotype of human gastriccancer[J].Clin Cancer Res,2005,11(4):1386-1393.
  • 6Mora L B,Buettner R,Seigne J,et al.Constitutive activation of Stat3in human prostate tumors and cell lines:direct inhibition of Stat3 sig-naling induces apoptosis of prostate cancer cells[J].Cancer Res,2002,62(22):6659-6666.
  • 7冯其柱,张超,李方跃,姚磊.肝细胞癌组织GRIM-19和STAT3蛋白的表达[J].安徽医科大学学报,2011,46(5):419-422. 被引量:5
  • 8Zhang L,Gao L,Li Y,et al.Effects of plasmid-based Stat3-specificshort hairpin RNA and GRIM-19 on PC-3M tumor cell growth[J].Clin Cancer Res,2008,14(2):559-568.
  • 9Yu H,Pardoll D,Jove R.STATs in cancer inflammation and immuni-ty:a leading role for STAT3[J].Nat Rev Cancer,2009,9(11):798-809.

二级参考文献14

  • 1龚龙波,罗学来,刘双又,陶德定,龚建平,胡俊波.GRIM-19及其靶基因产物STAT3与结直肠癌恶性程度的关系[J].癌症,2007,26(7):683-687. 被引量:43
  • 2Angell J E, Lindner D J, Shapiro P S, et al. Identification of GRIM- 19, a novel cell death-regulatoq gene induced by the interferon-be- ta and retinoic acid combination, using a genetic approach [ J ]. J Biol Chem ,2000,275 (43) :33416 - 26.
  • 3Fearnley I M,Carroll J,Shannon R J,et at. GRIM-19, a cell dealh regulatory. gene product, is a subunit of bovine mitochondrial NADH : ubiquinone oxidnreductase( complex I) [ J ]. J Biol Chem, 2001,276 (42) :38345 - 8.
  • 4Huang G, Lu H, Hao A, et al. GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex 1 [ J ]. Mol Cell Biol,2004,24 ( 19 ) : 8447 - 56.
  • 5Ma X, Kalakonda S, Srinivasula S M, et al. GRIM-19 associates with the se6ne protease HtrA2 for promoting celldeath [J]. Onco-gene,2007,26(33):4842 -9.
  • 6Gamero A M, Young H A, Wiltrout R H. Inactivation of Stat3 in tumor cells:releasing a brake on immune responses against cancer?[J]. Cancer Cell ,2004,5 (2) :111 - 2.
  • 7Jing N,Tweardy D J. Targeting Stat3 in cancer therapy [ J ]. Anti- cancer Drugs, 2005,16 ( 6 ) :601 - 7.
  • 8Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immu- nity:a leading role for STAT3[ J]. Nat Rev Cancer,2009,9 ( 11 ) : 798 - 809.
  • 9Zhang J, Yang J, Roy S K , et al. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3 [J]. Proc Natl Acad Sci U S A,2003,100(16) :9342 -7.
  • 10Kalakonda S, Nallar S C, Lindner D J, et al. Tumor-suppressive ac- tivity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3 [ J ]. Cancer Res, 2007,67(13) :6212 -20.

共引文献4

同被引文献9

  • 1Elfriede G, Andy N, Anne L, et al. Psychometric validation of the European Organisation for Research and Treatment of Caneer Quality of Life Questionnaire-Endometrial Cancer Module ( EORTC QLQ - EN24) [ J]. European Journal of Cancer,2011,47(2) :183 -190.
  • 2Srinivas KC, Monika J, Val G,et al. Risk factors to predict the inci- dence of surgical adverse events following open or laparoscopic sur- gery for apparent early stage endometrial cancer: Results from a ran- domised controlled trial[ J]. European Journal of Cancer,2012,48 (14) :2155 -2162.
  • 3Claudia BMB, Geertruida HB, Karin MV, et al. Laparoscopic hyster- ectomy is preferred over laparotomy in early endometrial cancer pa- tients, however not cost effective in the very obese[ J]. European Journal of Cancer,2011,47 ( 14 ) :2158 - 2165.
  • 4Emma JC, Chris R,Qian WD, et al. Body mass index does not influ- ence post-treatment survival in early stage endometrial cancer: Re- suits from the MRC ASTEC trial[ J]. European Journal of Cancer,2012,48 (6) :853 - 864.
  • 5Samir AF. Current surgical treatment option,utilizing robot-assisted laparoscopic surgery in obese women with endometrial cancer: Far- ghaly' s technique[J]. Journal of the Egyptian National Cancer In- stitute,2013,25(2) :57 -61.
  • 6董莉莳,王海琳.STAT3及VEGF在子宫内膜癌组织中的表达研究[J].中国妇幼保健,2008,23(33):4762-4764. 被引量:9
  • 7莫训群,姚军,黄梦婷.STAT3在子宫内膜癌组织中的表达及与ER、PR相关性研究[J].华中科技大学学报(医学版),2013,42(1):78-82. 被引量:12
  • 8朱丽霞,刘琴,李海,徐松,冯一中,胡建铭.子宫内膜癌中STAT3蛋白的表达及临床意义[J].现代肿瘤医学,2013,21(3):630-632. 被引量:12
  • 9蔡玲玉,贺银燕,席晓薇,张箴波,万小平.雌激素跨膜受体GPR30介导子宫内膜癌中IL-6/STAT3炎症信号通路的激活[J].现代妇产科进展,2013,22(6):437-440. 被引量:6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部